We are live on ! Find out more
BME icon

BlackRock Health Sciences Trust

37 hedge funds and large institutions have $29.9M invested in BlackRock Health Sciences Trust in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 11

5% less funds holding

Funds holding: 3937 (-2)

10.83% less ownership

Funds ownership: 19.14%8.32% (-11%)

14% less capital invested

Capital invested by funds: $34.5M → $29.9M (-$4.68M)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
37
Holders Change
-2
Holders Change %
-5.13%
% of All Funds
0.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
10
Reduced
11
Closed
6
Calls
Puts
Net Calls
Net Calls Change

BME Hedge Fund Activity: Q2 2018 in Review

37 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust (BME) for Q2 2018, worth a combined $29.9M — down 14% from $34.5M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BME and 4 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 10 added.

The largest buyer was Invesco, adding an estimated $1.03M. The largest seller was Truvvo Partners, exiting entirely with an estimated $4.63M sold.

  • 37 institutional investors held BlackRock Health Sciences Trust (BME) as of Q2 2018, down from 39 in Q1 2018.
  • Funds reported $29.9M of BlackRock Health Sciences Trust stock for Q2 2018, down 14% quarter-over-quarter.
  • 4 funds opened new BlackRock Health Sciences Trust positions in Q2 2018 and 6 closed out, a net change of -2 holders.
  • The largest BlackRock Health Sciences Trust buyer in Q2 2018 was Invesco, an estimated $1.03M added.
  • The largest BlackRock Health Sciences Trust seller in Q2 2018 was Truvvo Partners, an estimated $4.63M sold.

Based on aggregated 13F filings for Q2 2018.